Epilepsy medicines at AES 2026
Dec 4–8, 2026 Denver, CO ~6.2k attendees Website
18 organizations at AES 2026 present work in epilepsy medicines. 18 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–18 of 18 organizations
| Organization | AES 2026 Attendance |
|---|---|
Acadia Pharmaceuticals San Diego, CA | |
Neuroscience biopharma whose approved medicines treat Rett syndrome and Parkinson’s disease psychosis, with a pipeline for other rare neurological diseases. | Booth Exhibiting at Booth 700 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3022 |
Aucta Pharmaceuticals Piscataway, NJ | |
Formulation-focused drug company for CNS disorders; its first branded product is Motpoly XR, a once-daily lacosamide. | Booth Exhibiting at Booth 3603 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Azurity Pharmaceuticals Atlanta, GA | |
Privately held specialty pharmaceutical company making accessible formulations of medicines for underserved patients. | Booth Exhibiting at Booth 3806 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Biocodex Bedminster, NJ | |
U.S. arm of a family-owned French drug company; it markets Diacomit (stiripentol) for seizures in Dravet syndrome. | Booth Exhibiting at Booth 2612 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Biohaven New Haven, CT | |
Biopharma developing neurology medicines, including a Kv7 potassium-channel activator in clinical trials for focal epilepsy. | Booth Exhibiting at Booth 2012 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3124 |
GRIN Therapeutics New York, NY | |
Develops targeted therapies for pediatric neurodevelopmental disorders driven by NMDA receptor dysfunction, such as GRIN-related disorders. | Booth Exhibiting at Booth 1212 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Harmony Biosciences Plymouth Meeting, PA | |
Develops and markets treatments for rare neurological diseases, with drugs in development for Dravet syndrome and Lennox-Gastaut syndrome. | Booth Exhibiting at Booth 1518 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
J2 Bio-Pharma Las Vegas, NV | |
Privately held specialty pharmaceutical company reformulating neurology medications. | Booth Exhibiting at Booth 2016 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Jazz Pharmaceuticals Palo Alto, CA | |
Global biopharma with medicines for epilepsies, sleep disorders and cancers, including Epidiolex (cannabidiol) for seizures in rare epilepsies. | Booth Exhibiting at Booth 2601 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor offices O3822, O3824, O3922 and O3924 |
Lundbeck Valby, Denmark | |
Danish biopharma focused on brain diseases; its epilepsy pipeline includes bexicaserin for developmental and epileptic encephalopathies. | Booth Exhibiting at Booth 2615 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Neurelis San Diego, CA | |
Neuroscience company whose Valtoco diazepam nasal spray treats seizure clusters. | Booth Exhibiting at Booth 2901 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor office O3122 |
OWP Pharmaceuticals Naperville, IL | |
U.S. maker of neurology and psychiatry medicines that donates its profits to the ROW Foundation for epilepsy care worldwide. | Booth Exhibiting at Booth 3400, 3500 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Booth Exhibiting at Booth 3404 · OWP Medical Affairs |
Praxis Precision Medicines Boston, MA | |
Clinical-stage biopharma using insights from genetic epilepsies to develop therapies for disorders of brain excitability. | Booth Exhibiting at Booth 1612 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm Exhibit floor offices O3422, O3424, O3522 and O3524 |
Rapport Therapeutics Boston, MA | |
Clinical-stage biotech developing precision neuroscience medicines, including RAP-219 for focal epilepsy. | Booth Exhibiting at Booth 605 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
SK Life Science Paramus, NJ | |
U.S. arm of South Korea’s SK Biopharmaceuticals; it markets Xcopri (cenobamate) for partial-onset seizures in adults. | Booth Exhibiting at Booth 2001 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
UCB Smyrna, GA | |
Belgian biopharma focused on neurology and immunology; its epilepsy medicines include Briviact, Fintepla and Nayzilam. | Booth Exhibiting at Booth 2301, 2607 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Upsher-Smith Maple Grove, MN | |
U.S. pharmaceutical company, part of Bora Group, whose products include epilepsy medicines. | Booth Exhibiting at Booth 1601 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Xenon Pharmaceuticals Burnaby, BC, Canada | |
Neuroscience biopharma with late-stage epilepsy trials, led by azetukalner, a Kv7 potassium-channel opener for focal seizures. | Booth Exhibiting at Booth 2807 Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm |
Instantly find 20 buyers in epilepsy medicines
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AES 2026 by
Organization type
Focus area
- Rare and genetic epilepsies 47
- EEG and monitoring 45
- Patient and family support 32
- Epilepsy medicines 18
- Epilepsy surgery 16
- Software and AI 16
- Clinical trials and registries 14
- Training and certification 9
- Neuromodulation 8
- Genetic testing 7
- Brain mapping and MEG 7
- Gene, cell and RNA therapies 5
- Preclinical research 5
- Wearables and seizure alerts 4
- Careers and recruiting 3
Exhibit hall
Everyone
Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction